SCHEMBL6622341

SCHEMBL6622341

COc1ccc(-c2n[nH]nc2-c2nc(C)cs2)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.40
MAPT P10636 2/20 0.40
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMO O15229 1/20 0.37
TGFBR1 P36897 2/20 0.37
BMPR1A P36894 1/20 0.37
SMAD2 Q15796 1/20 0.37
GRM2 Q14416 2/20 0.36
PTGS2 P35354 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6620807 0.86 ALDH1A1 (0.48) POLBMAPTALDH1A1KDM4EMEN1
SCHEMBL6623201 0.80 MEN1 (0.46) POLBMAPTALDH1A1KDM4ETDP1
SCHEMBL411466 0.76 TGFBR1 (0.43) MAPTALDH1A1ADORA2AADORA1NPC1
SCHEMBL6313738 0.73 MAPT (0.49) MAPTALDH1A1ADORA2AADORA1NPC1
SCHEMBL17141347 0.73 ALDH1A1 (0.50) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL6314174 0.71 ALDH1A1 (0.47) MAPTALDH1A1ADORA2AADORA1NPC1
SCHEMBL13629590 0.71 KDM4E (0.56) POLBMAPTALDH1A1KDM4ETDP1
SCHEMBL22816288 0.70 ALDH1A1 (0.50) POLBMAPTALDH1A1KDM4ETDP1
SCHEMBL22816289 0.70 ALDH1A1 (0.50) POLBMAPTALDH1A1KDM4ETDP1
SCHEMBL6796072 0.70 AOC3 (0.38) MAPTALDH1A1KDM4ETDP1TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040266842-A1 Thiazolyl substituted triazoles as alk5 inhibitors GASTER LARAMIE MARY 2004-12-30 US claimed
EP-1444227-A1 THIAZOLYL SUBSTITUTED TRIAZOLES AS ALK5 INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-08-11 EP claimed
WO-2003042207-A1 THIAZOLYL SUBSTITUTED TRIAZOLES AS ALK5 INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-05-22 WO claimed
US-20040266842-A1 Thiazolyl substituted triazoles as alk5 inhibitors GASTER LARAMIE MARY 2004-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266842-A1 Thiazolyl substituted triazoles as alk5 inhibitors CBR3, CBR1, ALK POLB 2560/4885MAPT 4735/4885ALDH1A1 1905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.